Lung Transplant Research Today is a free monthly online journal that collates and summarizes the latest research about Lung Transplant, including details on risks, prognosis, procedure, surgery, organ donation.

Volume 1 (2005), Issue 5 (May)

1. Bile acid aspiration and the development of bronchiolitis obliterans after lung transplantation.
   J Thorac Cardiovasc Surg, 129(5): 1144-52. [Abstract] [Full-text]
2. Adenosine A2A receptor activation reduces inflammation and preserves pulmonary function in an in vivo model of lung transplantation.
   J Thorac Cardiovasc Surg, 129(5): 1137-43. [Abstract] [Full-text]
3. Respiratory disorders and quality of sleep in patients on the waiting list for lung transplantation.
   Transplant Proc, 37(3): 1537-9. [Abstract] [Full-text]
4. Long-term results of lung transplantation for emphysema.
   Transplant Proc, 37(3): 1530-3. [Abstract] [Full-text]
5. Pulmonary tailoring and lobar transplantation to overcome size disparities in lung transplantation.
   Transplant Proc, 37(3): 1526-9. [Abstract] [Full-text]
6. Analysis of lung transplant recipients surviving beyond 5 years.
   Transplant Proc, 37(3): 1523-5. [Abstract] [Full-text]
7. Pediatric lung transplantation.
   Transplant Proc, 37(3): 1519-22. [Abstract] [Full-text]
8. Pulmonary infections increase exhaled nitric oxide in lung transplant recipients: a longitudinal study.
   Clin Transplant, 19(3): 377-82. [Abstract] [Full-text]
9. Early onset post-transplant lymphoproliferative disease is associated with allograft localization.
   Clin Transplant, 19(3): 327-34. [Abstract] [Full-text]
10. Major depression and the use of electroconvulsive therapy (ECT) in lung transplant recipients.
    Psychosomatics, 46(3): 244-9. [Abstract] [Full-text]
11. Detection of chronic rejection by quantitative ventilation scintigrams in lung-transplanted patients: a pilot study.
    Clin Physiol Funct Imaging, 25(3): 183-7. [Abstract] [Full-text]
12. Broncho-alveolar lavage matrix metalloproteases as a sensitive measure of bronchiolitis obliterans.
    Am J Transplant, 5(6): 1548-52. [Abstract] [Full-text]
13. Differences in CMV-specific T-cell levels and long-term susceptibility to CMV infection after kidney, heart and lung transplantation.
    Am J Transplant, 5(6): 1483-9. [Abstract] [Full-text]
14. Tacrolimus pharmacokinetics and dose monitoring after lung transplantation for cystic fibrosis and other conditions.
    Am J Transplant, 5(6): 1477-82. [Abstract] [Full-text]
15. Acute renal failure after lung transplantation: incidence, predictors and impact on perioperative morbidity and mortality.
    Am J Transplant, 5(6): 1469-76. [Abstract] [Full-text]
16. A trial of valganciclovir prophylaxis for cytomegalovirus prevention in lung transplant recipients.
    Am J Transplant, 5(6): 1462-8. [Abstract] [Full-text]
17. Everolimus alters the bronchoalveolar lavage and endobronchial biopsy immunologic profile post-human lung transplantation.
    Am J Transplant, 5(6): 1446-51. [Abstract] [Full-text]
18. Pirfenidone inhibits lung allograft fibrosis through L-arginine-arginase pathway.
    Am J Transplant, 5(6): 1256-63. [Abstract] [Full-text]
19. In vivo molecular imaging characterizes pulmonary gene expression during experimental lung transplantation.
    Am J Transplant, 5(6): 1216-25. [Abstract] [Full-text]
20. Analysis of the different histologic lesions observed in transbronchial biopsy for the diagnosis of acute rejection. Clinicopathologic correlations during the first 6 months after lung transplantation.
    Hum Pathol, 36(4): 387-94. [Abstract] [Full-text]
21. Recurrence of pulmonary veno-occlusive disease after heart-lung transplantation.
    J Heart Lung Transplant, 24(5): 635-7. [Abstract] [Full-text]
22. Pulmonary embolization of microcrystalline cellulose in a lung transplant recipient.
    J Heart Lung Transplant, 24(5): 624-7. [Abstract] [Full-text]
23. Extended ganciclovir prophylaxis in lung transplantation.
    J Heart Lung Transplant, 24(5): 583-7. [Abstract] [Full-text]
24. Effects of inhaled FK 506 on the suppression of acute rejection after lung transplantation: use of a rat orthotopic lung transplantation model.
    J Heart Lung Transplant, 24(5): 538-43. [Abstract] [Full-text]
25. A descriptive study of small airway reticular basement membrane thickening in clinically stable lung transplant recipients.
    J Heart Lung Transplant, 24(5): 533-7. [Abstract] [Full-text]
26. Synergistic effect of low dose cyclosporine A and human interleukin 10 overexpression on acute rejection in rat lung allotransplantation.
    Eur J Cardiothorac Surg, 27(6): 1030-5. [Abstract] [Full-text]
27. Cumulative risk adjusted monitoring of 30-day mortality after cardiothoracic transplantation: UK experience.
    Eur J Cardiothorac Surg, 27(6): 1022-9. [Abstract] [Full-text]
28. The effect of primary graft dysfunction on survival after lung transplantation.
    Am J Respir Crit Care Med, 171(11): 1312-6. [Abstract] [Full-text]
29. Obliterative airway disease in rat tracheal allografts requires tumor necrosis factor alpha.
    Exp Mol Pathol, 78(3): 190-7. [Abstract] [Full-text]

© 2005-2010 Lung Transplant Research Today. All Rights Reserved.